{
    "nctId": "NCT04654208",
    "briefTitle": "Swedish Ibrance Registries Insights (SIRI)",
    "officialTitle": "Palbociclib Treatment Patterns in Swedish Patients With Metastatic Breast Cancer - Swedish Ibrance Registries Insights (SIRI)",
    "overallStatus": "RECRUITING",
    "conditions": "Malignant Neoplasm of Breast",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 1500,
    "primaryOutcomeMeasure": "Proportion of patients on treatment",
    "eligibilityCriteria": "Inclusion Criteria:\n\nPatients must meet all of the following inclusion criteria to be eligible for inclusion in the study:\n\n1. One or more (\u22651) filled prescription of palbociclib (ATC code: L01XE33)\n2. Age \u226518 years at index date\n\nExclusion Criteria:\n\nThere are no exclusion criteria",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}